NuvoNuro
Austin, Texas, United States • 1-10 Employees
Company overview
| Headquarters | PO Box 7465, Austin, TX 78713, US |
| Founded | 2016 |
| Employees | 1-10 |
Key Contact at NuvoNuro
Stephen Martin
Co-Founder and President
About NuvoNuro
NuvoNuro is a neuroscience company in Austin, TX with a translational focus on developing drugs for traumatic brain injury and other neurological disorders by a new mechanism of action. NuvoNuro was cofounded by Professor Stephen Martin and Dr. James Sahn (The University of Texas at Austin), who have established active collaborations nationwide with scientists, physicians, and consultants. The team is interested in preclinical drug development for traumatic brain injury (TBI) and other unmet medical needs in neuroscience.
NuvoNuro revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the current industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
NuvoNuro has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
NuvoNuro has never raised funding before.
Canada
United Kingdom
South Africa
BelgiumFrequently asked questions
4.8
40,000 users
